SKI Market

Indian Indices

Nifty

18,487.75 -46.65
(-0.25%)

Sensex

62,428.54 -193.70
( -0.31%)

Bank Nifty

43,790.20 -337.95
( -0.77%)

Nifty IT

29,446.25 126.50
( 0.43%)

Global Indices

Nasdaq

12,935.29 -82.14
(-0.63%)

Dow Jones

32,908.27 -134.51
(-0.41%)

Hang Seng

18,216.91 -17.36
(-0.10%)

Nikkei 225

31,148.01 260.13
(0.84%)

Forex

USD-INR

82.68 0.09
(0.11%)

EUR-INR

88.62 0.09
(0.10%)

GBP-INR

102.43 0.42
(0.41%)

JPY-INR

0.59 0.00
(0.37%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Panacea Biotec Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

531349

INE922B01023

54.5144503

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PANACEABIO

719.39

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)	Mar 2018 ( Cr)	Mar 2017 ( Cr)
Sales Turnover	235.50	343.56	158.09	96.21	183.98	544.03
Excise Duty	0.00	0.00	0.00	0.00	0.26	13.94
Net Sales	235.50	343.56	158.09	96.21	183.72	530.09
Other Income	12.57	20.75	30.88	321.50	83.79	61.21
Stock Adjustments	60.95	-14.24	28.18	-17.12	3.97	9.80
Total Income	309.02	350.07	217.15	400.59	271.48	601.10
EXPENDITURE :
Raw Materials	173.04	162.02	86.71	59.13	92.05	178.63
Power & Fuel Cost	26.51	20.78	17.58	22.72	20.94	28.08
Employee Cost	72.50	59.47	46.64	41.16	35.97	132.21
Other Manufacturing Expenses	40.76	45.75	19.05	18.47	17.72	41.19
Selling & Administrative Expenses	45.82	30.87	21.56	17.38	13.95	66.37
Miscellaneous Expenses	10.51	9.97	129.41	66.89	15.17	69.01
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	369.13	328.85	320.94	225.75	195.80	515.49
Operating Profit	-60.11	21.21	-103.80	174.84	75.69	85.60
Interest	7.04	7.52	5.27	104.63	103.23	103.50
Gross Profit	-67.15	13.69	-109.07	70.21	-27.54	-17.90
Depreciation	26.43	26.57	26.91	33.03	33.69	66.15
Profit Before Tax	-93.58	-12.88	-135.98	37.18	-61.23	-84.05
Tax	0.00	2.27	39.88	7.48	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	-0.71	-22.78	3.13	10.64	-11.38
Reported Net Profit	-93.58	-14.44	-153.07	26.57	-71.88	-72.66
Extraordinary Items	0.01	3.26	-31.37	302.79	0.00	-37.92
Adjusted Net Profit	-93.59	-17.70	-121.70	-276.22	-71.88	-34.74
Adjustment below Net Profit	0.50	1.38	-3.03	-0.65	-1.42	-0.77
P & L Balance brought forward	5.12	18.18	174.27	148.35	221.64	295.07
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-87.96	5.12	18.18	174.27	148.35	221.64
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-15.28	-2.36	-24.99	4.34	0.00	0.00
Earnings Per Share(Adj)-Unit Curr	-15.28	-2.36	-22.93	3.98	0.00	0.00
Book Value-Unit Curr	64.24	79.43	136.97	66.75	61.79	72.85
Book Value(Adj)-Unit Curr	64.24	79.43	125.66	61.24	56.69	66.83

18,487.75 -46.65 (-0.25%)

62,428.54 -193.70 ( -0.31%)

43,790.20 -337.95 ( -0.77%)

29,446.25 126.50 ( 0.43%)

12,935.29 -82.14 (-0.63%)

32,908.27 -134.51 (-0.41%)

18,216.91 -17.36 (-0.10%)

31,148.01 260.13 (0.84%)

82.68 0.09 (0.11%)

88.62 0.09 (0.10%)

102.43 0.42 (0.41%)

0.59 0.00 (0.37%)